Actinogen Medical Limited

ASX:ACW 株式レポート

時価総額：AU$76.6m

Actinogen Medical マネジメント

マネジメント 基準チェック /24

Actinogen Medicalの CEO はSteve Gourlayで、 Mar2021年に任命され、 の在任期間は 3.67年です。 の年間総報酬はA$ 754.11Kで、 54.7%給与と45.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の4.41%を直接所有しており、その価値はA$ 3.38M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と6.9年です。

主要情報

Steve Gourlay

最高経営責任者

AU$754.1k

報酬総額

CEO給与比率54.7%
CEO在任期間3.7yrs
CEOの所有権4.4%
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間6.9yrs

経営陣の近況

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

CEO報酬分析

Actinogen Medical の収益と比較して、Steve Gourlay の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024AU$754kAU$412k

-AU$13m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

報酬と市場: Steveの 総報酬 ($USD 490.35K ) は、 Australian市場 ($USD 298.55K ) の同規模の企業の平均を上回っています。

報酬と収益: Steveの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Steve Gourlay (65 yo)

3.7yrs

在職期間

AU$754,111

報酬

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k4.41%
A$ 3.4m
William Souter
Chief Financial Officerless than a yearAU$476.62k0.014%
A$ 10.4k
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.8yrsAU$913.27kデータなし
Michael Roberts
Head of Investor Relations & Corporate Communications3.5yrsデータなしデータなし
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.8yrsAU$191.66kデータなし
Fujun Li
Head of Manufacturing1.3yrsデータなしデータなし
Andrew Udell
Chief Commercial Officerless than a yearデータなしデータなし
Peter Webse
Company Secretary11.1yrsデータなしデータなし

2.3yrs

平均在職期間

63yo

平均年齢

経験豊富な経営陣: ACWの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k4.41%
A$ 3.4m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.8yrsAU$913.27kデータなし
George Morstyn
Independent Non-Executive Director6.9yrsAU$114.27k0.46%
A$ 354.7k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.7yrsAU$234.39k0.70%
A$ 533.6k
Colin Masters
Member of Xanamem Clinical Advisory Board9.7yrsデータなしデータなし
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.7yrsデータなしデータなし
Malcolm McComas
Independent Non-Executive Director5.6yrsAU$114.27k0.28%
A$ 212.5k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.8yrsデータなしデータなし
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.7yrsデータなしデータなし
Jonathan Seckl
Member of Scientific Advisory Boardno dataデータなしデータなし
Brian Walker
Member of Scientific Advisory Boardno dataデータなしデータなし
Scott Webster
Member of Scientific Advisory Boardno dataデータなしデータなし

6.9yrs

平均在職期間

71yo

平均年齢

経験豊富なボード: ACWの 取締役会 は 経験豊富 であると考えられます ( 6.9年の平均在任期間)。